PepGen (PEPG) Retained Earnings (2021 - 2026)
PepGen (PEPG) posted Retained Earnings of -$378.9 million for Q1 2026, down 3444645.45% sequentially from $11000.0 in Q4 2025, and down 1722172.73% YoY from N/an in Q1 2025.
Analysis
PepGen (PEPG) Retained Earnings (2021 - 2026) Analysis & Trends
PepGen has reported Retained Earnings for 6 years, with the latest figure at -$378.9 million in Q1 2026.
- Quarterly Retained Earnings fell 1722172.73% year-over-year to -$378.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$378.9 million (down 1722172.73% YoY) and the FY2025 annual result came in at $11000.0, down 52.17% from the prior year.
- Retained Earnings fell to -$378.9 million in Q1 2026 per PEPG's latest filing, from $11000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $23000.0 in Q4 2024 and troughed at -$378.9 million in Q1 2026.
- A 5-year average of -$124.7 million and a median of -$87.9 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings jumped 100.01% in 2024, then plunged 1722172.73% in 2026.
- Over 5 years, Retained Earnings stood at -$81000.0 in 2022, then plunged by 223951.85% to -$181.5 million in 2023, then soared by 100.01% to $23000.0 in 2024, then plunged by 52.17% to $11000.0 in 2025, then plunged by 3444645.45% to -$378.9 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$378.9 million, $11000.0, and -$342.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.10 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -4.00 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.05 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 4.38 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.57 Bn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | -396.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -396.70 Mn |
| Mar 31, 2026 | -378.90 Mn |
| Dec 31, 2025 | -361.12 Mn |
| Sep 30, 2025 | -342.80 Mn |
| Jun 30, 2025 | -324.80 Mn |
| Mar 31, 2025 | -301.70 Mn |
| Dec 31, 2024 | -271.46 Mn |
| Sep 30, 2024 | -249.22 Mn |
| Jun 30, 2024 | -227.84 Mn |
| Mar 31, 2024 | -199.50 Mn |
| Dec 31, 2023 | -181.48 Mn |
| Sep 30, 2023 | -162.00 Mn |
| Jun 30, 2023 | -138.70 Mn |
| Mar 31, 2023 | -119.20 Mn |
| Dec 31, 2022 | -102.86 Mn |
| Sep 30, 2022 | -87.92 Mn |
| Jun 30, 2022 | -69.31 Mn |
| Mar 31, 2022 | -52.00 Mn |
| Dec 31, 2021 | -33.75 Mn |